Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT5 | Q9NXA8 | 5/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 13/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 12/20 | 0.51 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.49 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14286269 | 1.00 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL14264834 | 1.00 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL3503087 | 0.99 | SIRT5 (0.51) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL2268022 | 0.94 | SIRT5 (0.57) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL10884941 | 0.94 | SIRT5 (0.56) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| Hydrochloric Acid SCHEMBL10943848 | 0.94 | SIRT5 (0.56) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL17289476 | 0.93 | SIRT5 (0.55) | SIRT5SIRT2SIRT1SIRT3TGM2 | |
| SCHEMBL1529286 | 0.93 | SIRT2 (0.48) | SIRT5SIRT2SIRT1SIRT3 | |
| Acetic Acid SCHEMBL8862727 | 0.91 | SIRT2 (0.46) | SIRT5SIRT2SIRT1SIRT3 | |
| SCHEMBL9763743 | 0.91 | ALDH1A1 (0.48) | SIRT5SIRT2SIRT1SIRT3TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 464 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119842867-A | Stable rivaroxaban content detection kit with strong anti-interference capability | 北京九强生物技术股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-115290581-A | anti-Xa assay kit (chromogenic substrate method) | 上海太阳生物技术有限公司 | 2022-11-04 | — | — | CN | claimed |
| US-20250179523-A1 | METHODS FOR THE PURIFICATION OF VIRAL VECTORS | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2025-06-05 | — | — | US | disclosed |
| CN-119842867-A | Stable rivaroxaban content detection kit with strong anti-interference capability | 北京九强生物技术股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-12173307-B2 | Methods for the purification of viral vectors | BIOVERATIV THERAPEUTICS INC. (US) | 2024-12-24 | — | — | US | disclosed |
| CN-118221785-A | Novel AAV variants | 上海药明康德新药开发有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113518824-B | Novel AAV variants | 上海药明康德新药开发有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-114207196-B | Novel AAV libraries | 上海药明康德新药开发有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117106856-A | anti-Xa activity assay kit and preparation method thereof | 武汉塞力斯生物技术有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-115290581-B | Anti-Xa assay kit and method for detecting anti-Xa activity | 上海太阳生物技术有限公司 | 2023-10-13 | — | — | CN | disclosed |
| EP-4171657-A1 | METHODS FOR THE REMOVAL OF FREE FACTOR VIII FROM PREPARATIONS OF LENTIVIRAL VECTORS MODIFIED TO EXPRESS SAID PROTEIN | Bioverativ Therapeutics Inc. (US) | 2023-05-03 | — | — | EP | disclosed |
| EP-0672659-A1 | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-09-20 | — | — | EP | disclosed |
| EP-0671390-A2 | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995023608-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | disclosed |
| WO-1995023609-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | disclosed |
| EP-0670310-A1 | Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants | ELI LILLY AND COMPANY (US) | 1995-09-06 | — | — | EP | disclosed |
| US-5441965-A | Administering a substituted benzothiophene compound | ELI LILLY AND COMPANY (US) | 1995-08-15 | — | — | US | disclosed |
| US-5439888-A | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-08-08 | — | — | US | disclosed |
| EP-0664126-A1 | Inhibition of thrombin | ELI LILLY AND COMPANY (US) | 1995-07-26 | — | — | EP | disclosed |
| US-5436229-A | Di- and tripeptides as anticoagulants | ELI LILLY AND COMPANY (US) | 1995-07-25 | — | — | US | disclosed |